| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 102.298 | 184.336 | 192.869 | 201.580 |
| Total Income - EUR | - | - | - | - | - | 0 | 102.482 | 184.341 | 192.879 | 201.595 |
| Total Expenses - EUR | - | - | - | - | - | 7.796 | 104.670 | 174.991 | 188.206 | 200.379 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -7.796 | -2.188 | 9.350 | 4.673 | 1.217 |
| Net Profit/Loss - EUR | - | - | - | - | - | -7.796 | -2.949 | 7.863 | 3.106 | 1.022 |
| Employees | - | - | - | - | - | 1 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Any Medpharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 4.841 | 4.178 | 3.609 | 3.018 | 2.447 |
| Current Assets | - | - | - | - | - | 9.140 | 48.746 | 64.694 | 75.975 | 78.906 |
| Inventories | - | - | - | - | - | 1.364 | 36.460 | 43.407 | 47.388 | 46.555 |
| Receivables | - | - | - | - | - | 5.455 | 10.897 | 15.786 | 11.124 | 11.584 |
| Cash | - | - | - | - | - | 2.321 | 1.390 | 5.501 | 17.462 | 20.768 |
| Shareholders Funds | - | - | - | - | - | -7.754 | -10.531 | -2.702 | 413 | 1.432 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 25.186 | 65.697 | 71.560 | 78.580 | 79.921 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Any Medpharm S.r.l.